Aclaris Therapeutics, Inc.

ACRS · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.6B · 73 employees
225
SEC Filings
$4.52
Close 2026-05-22
73
Employees

Business Summary

, Part I, Item 1A. Risk Factors, and Part II, Item7. Managements Discussion and Analysis of Financial Condition and Results of Operations, but are also contained elsewhere in this Annual Report. In some cases, you can identify forward-looking statements by the words may, might, can, will, to be, could, would, should, expect, intend, plan, objective, anticipate, believe, estimate, predict, project, potential, likely, continue and ongoing, or the negative of these terms, or other comparable termin...

Latest Stock Quote

ACRS 2026-05-22 $4.52 O:$4.54 H:$4.6 L:$4.495 Vol:0.6M VWAP:$4.5303
origin leaf: f2ea1572507e54b10787acab1c90b4e948930b042338e0db3465bd3c2bdc005b

Next Earnings

Q2 FY2026 — expected 2026-08-14

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001104659-26-020540EDGAR88K words
2025-02-272024-12-310001558370-25-001819EDGAR
2024-02-272023-12-310001558370-24-001753EDGAR
2023-02-232022-12-310001558370-23-001829EDGAR
2022-02-242021-12-310001558370-22-001838EDGAR
2021-02-252020-12-310001558370-21-001717EDGAR
2020-02-252019-12-310001558370-20-001325EDGAR
2019-03-182018-12-310001558370-19-002211EDGAR
2018-03-122017-12-310001558370-18-001866EDGAR
2017-03-152016-12-310001558370-17-001802EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001104659-25-107788EDGAR24K words
2025-08-072025-06-300001558370-25-010789EDGAR
2025-05-082025-03-310001558370-25-006993EDGAR
2024-11-062024-09-300001558370-24-014646EDGAR
2024-08-072024-06-300001558370-24-011376EDGAR
2024-05-072024-03-310001558370-24-007069EDGAR
2023-11-062023-09-300001558370-23-017660EDGAR
2023-08-072023-06-300001558370-23-013491EDGAR
2023-05-082023-03-310001558370-23-008382EDGAR
2022-11-082022-09-300001558370-22-016738EDGAR
2022-08-032022-06-300001558370-22-011757EDGAR
2022-05-102022-03-310001558370-22-007972EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-110001104659-26-026407EDGAR1K words
2026-03-100001104659-26-025420EDGAR
2026-02-260001104659-26-020070EDGAR
2026-01-120001104659-26-002694EDGAR
2026-01-060001104659-26-001076EDGAR
2025-11-060001104659-25-107353EDGAR
2025-10-140001104659-25-098991EDGAR
2025-08-070001558370-25-010640EDGAR
2025-07-290001558370-25-009739EDGAR
2025-06-300001558370-25-008984EDGAR

225 total filings indexed. 193 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001557746
TickerACRS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.aclaristx.com
Listed2015-10-07

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 3f536313491fbaa6efd9fafb0a81f517e86567297a0cbe5bf39ec47b7a7be923
parent: 38649b9528789aea8c657c2cb9ee9acff71d3c4642cf2036cd26be925af6b27a
content hash: 879d4556f40246e71f9a47707404462c34b20ef8bdc1627a2e53d1c4c5963715
signed: 2026-06-02T19:00:04.171Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf